Pharma Journalist 9038 posts 0 comments

Allergan, an AbbVie Company and Molecular Partners, a clinical-stage biotechnology company developing a new class of custom-built protein therapeutics known as DARPin therapeutics,…
Read More...

Moderna, Inc. and Catalent, Inc. announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at…
Read More...

Aldevron announced an agreement with Ziopharm Oncology to produce plasmid DNA for T cell therapy of solid tumors. Aldevron has developed the neoGMP service level designed to address…
Read More...

PPD, Inc. has expanded its laboratory test portfolio by adding five new molecular, serology and functional assays designed expressly for COVID-19 vaccine and therapy development…
Read More...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, announced the U.S. Food and Drug Administration (FDA) has cleared its investigational…
Read More...

Theravance Biopharma, Inc. announced that the first COVID-19 patient has been dosed in a Phase 2 study of TD-0903. TD-0903 is a lung-selective, nebulized Janus kinase inhibitor (JAKi)…
Read More...

Avalon GloboCare Corp. announced a strategic partnership with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine that can be…
Read More...

Noxopharm, a clinical-stage Australian drug development company, has announced commencement of its NOXCOVID clinical program with a planned Phase I trial in Europe. This action is…
Read More...

Zogenix, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved FINTEPLA (fenfluramine) oral solution, CIV for the treatment of seizures associated with Dravet…
Read More...

SMi reports: Registration is now open for the 4th annual Ophthalmic Drugs Conference, taking place in London on the 23rd-24th November 2020. SMi presents the 4th Annual Ophthalmic…
Read More...